Dr. Marshall Summar is the Chief Executive Officer of Uncommon Cures LLC, a rare disease clinical trials company. In this role, he focuses on physically consolidating trials and using innovative technology to reduce the time and cost associated with developing new therapies in the rare disease field. He is a board-certified physician in pediatrics, biochemical genetics, and clinical genetics, specializing in genetics and rare diseases.
From 2010 to 2022, Dr.